Form 4: Procept BioRobotics Director Thomas Krummel Reports Acquisition of Stock and Options

Director Thomas Krummel reports acquisition of restricted stock units and stock options in Procept BioRobotics Corp.

Summary

• On June 4, 2024, Thomas M. Krummel, a director of Procept BioRobotics Corp, reported the acquisition of 1,376 restricted stock units (RSUs) and 2,526 stock options.
• The RSUs vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, contingent upon continued service.
• The stock options, granted on the same date, also vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, subject to continued service.
• Following these transactions, Krummel beneficially owns 47,007 shares of common stock and 2,526 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine transactions. The acquisition of shares and options by a director can be seen as a mildly positive sign, but it's a standard occurrence.

Positives

• The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
• The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Future Outlook

The vesting of the RSUs and stock options is contingent upon continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the beneficial ownership of securities by a director of Procept BioRobotics.

Stakeholder Impact

• The acquisition of RSUs and stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates